Genomic biomarkers to improve ulcerative colitis neoplasia surveillance

American Journal of Pathology

Volumn 173, Issue 6, 2008, Pages 1853-1860

  Bronner, Mary P ^a   O'Sullivan, Jacintha N ^e   Rabinovitch, Peter S ^b,c   Crispin, David A ^b,c   Chen, Lu ^d   Emond, Mary J ^b   Rubin, Cyrus E ^c   Brentnall, Teresa A ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ANAPHASE; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CLINICAL ARTICLE; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENTROPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MARKER GENE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECTUM BIOPSY; SENSITIVITY AND SPECIFICITY; TELOMERE; ULCERATIVE COLITIS;

EID: 57149097663     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080250     Document Type: Article

References (37)

1. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JA, Allan RN: Cancer morbidity in ulcerative colitis. Gut 1982, 23:490-497
2. Ekbom A, Helmick C, Zack M, Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233
3. Collins Jr RH, Feldman M, Fordtran JS: Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987, 26:1654-1658
4. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardly JH: Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 11:931-968
5. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, Dean PJ, Kimmey M, Perera DR, Rabinovitch PS: DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103:1611-1620
6. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE: Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992, 103:1602-1610
7. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, Burmer GC: Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994, 2:369-378
8. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR: Microsatellite instability is present in non-neoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996, 56:1237-1240
9. Willenbucher RF, Zelman SJ, Ferrell LD, Moore II DH, Waldman FM: Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology 1997, 113:791-801
10. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, Bronner MP, Brentnall TA: DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer free. Am J Pathol 2003, 162:665-672
11. Chen R, Bronner MP, Crispin DA, Rabinovitch PS, Brentnall TA: Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions. Cancer Genet Cytogenet 2005, 162:99-106
12. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA: The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 2005, 26:1513-1519
13. Rutter MD, Saunders BP, Schofield G, Forbers A, Price AB, Talbot IC: Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53:256-260
14. Kiesslich R, Neurath MF: Chromoendoscopy: an evolving standard in surveillance for ulcerative colitis. Inflamm Bowel Dis 2004, 10:695-696
15. Rabinovitch PS, Dziadon S, Brentnall TA, Emond M, Crispin DA, Haggitt RC, Bronner MP: Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999, 59:5148-5153
16. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 1997, 6625:623-627
17. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS: Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284
18. von Zglinicki T: Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 2000, 908:99-110
19. Blackburn EH: Structure and function of telomeres. Nature 1991, 350:569-573
20. Hande MP, Samper E, Lansdorp P, Blasco MA: Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 1999, 144:589-601
21. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645
22. Bailey SM, Murnane JP: Telomeres, chromosome instability and cancer. Nucleic Acids Res 2006, 34:2408-2417
23. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall B, Wheeless L, Cox C: Guidelines for implementation of clinical DNA cytometry. Cytometry 1993, 14:472-477
24. O'Sullivan JN, Finley JC, Risques RA, Shen WT, Gollahon KA, Moskovitz AH, Gryaznov S, Harley CB, Rabinovitch PS: Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms. Cytometry A 2004, 58:120-131
25. Rotnitzky A, Jewell NP: Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika 1990, 77:485-497
26. McCullagh P, Nelder JA: Generalized Linear Models, ed 2. New York, Chapman and Hall, 1989, p 124ff
27. Pagano M, Gauvreau K: Principles of Biostatistics, ed 2. Pacific Grove, Brooks/Cole Publishing, 2000, pp. 1-525
28. Nowell PC: Mechanisms of tumor progression. Cancer Res 1986, 46:2203-2207
29. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991, 51:3075-3079
30. Buffinton GD, Doe WF: Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 1995, 19:911-918
31. Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A: Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 1998, 43:1088-1095
32. McKenzie SJ, Baker MS, Buffinton GD, Doe WF: Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996, 98:136-141
33. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996, 41:2078-2086
34. Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takagi S, Maekawa H, Toyota T: Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol 1998, 33:343-348
35. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B: Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392:300-303
36. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ: Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998, 58:3974-3985
37. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK, Lansdorp PM: Short telomeres on human chromosome 17p. Nat Genet 1998, 18:76-80